Letter to Editor: Recent Advancement in Blood Cancer Research and Management

Blood Cancer is one of the leading causes of death globally. As per National Foundation for Cancer Research 1.2 million people in the U.S alone is living with blood cancer [1]. According to the statistical data provided by Leukemia & Lymphoma Society every 3 minutes a new person is diagnosed with some type of blood cancer [2]. Adding to the complexity of the disease there is no accurate survival data available. Generally, blood cancers are of three distinct types affecting the leucocyte cells (Leukemia), lymphocytes (Lymphoma) and plasma cells like B lymphocytes (Myeloma). These are further sub-classified according to severity and effected cells. Recent advancements in diagnostic technique have significantly increased the survival rate.